Table 2.

Associations between Demographic, Clinical, and Psychosocial Factors and Mean Adherence and Slope before the Pandemic and 2 Metrics of Change in Adherence after the Onset of the Pandemic

Variable	Adherence before Breakpoint				Change in Adherence
	Mean Adherence		Slope		% Change in Mean Adherence		Slope
	Coefficient	P Value	Coefficient	P Value	Coefficient	P Value	Coefficient	P Value
Demographic factors
Age	0.14	0.21∗	–0.10	0.40∗	0.04	0.73	0.17	0.14∗
Race (n = 78)	14.43	0.0001†	3.56	0.06†	1.59	0.21†	1.14	0.29†
Sex	0.35	0.55†	3.34	0.07†	1.51	0.28†	0.26	0.61†
Education	0.002	0.97†	0.15	0.70†	1.50	0.22†	0.11	0.74†
Marital status	0.70	0.40†	0.06	0.81†	0.81	0.37†	0.11	0.74†
Employment	0.12	0.73†	0.67	0.41†	0.18	0.67†	1.12	0.29†
Household income (n = 51)	0.74	0.39†	1.13	0.29†	0.23	0.63†	0.50	0.48†
Clinical factors
Mean adherence before breakpoint	1.00	<0.001	0.03	0.77∗	0.03	0.81∗	0.14	0.21∗
Regimen complexity	0.03	0.79∗	–0.16	0.15∗	–0.07	0.55∗	0.05	0.62∗
Comorbidities	2.52	0.11†	0.44	0.51†	2.45	0.12†	0.13	0.72†
Psychosocial factors
Resilience	0.25	0.03∗	0.06	0.59∗	–0.09	0.43∗	0.34	0.002∗
Coping (n = 58)	–0.21	0.12∗	0.002	0.99∗	–0.08	0.56∗	–0.26	0.05∗
Glaucoma illness perception	–0.32	0.006∗	0.06	0.62∗	–0.04	0.75∗	–0.09	0.46∗
Glaucoma medication self-efficacy	0.17	0.14∗	0.14	0.23∗	0.14	0.23∗	0.13	0.27∗

Boldface indicates statistical significance.

^∗Spearman ρ.

^†Wilcoxon test.